A transformative technology for gene editing - clustered regularly interspaced short palindromic repeats (CRISPR) -- has become ubiquitous, at least in research laboratories, where scientists efficiently adopted CRISPR technology to manipulate genes of interest. Still, applying it for humans is associated with greater risks and faces ethical issues. However, alongside a too reckless experiment of a Chinese scientist who edited babies’ genomes, plenty of companies have made well-thought progress toward transferring gene editing technologies into the clinic. Here we make a brief but pithy review on up-to-date gene editing approaches and start-up companies active in this area.
The congress will showcase the latest technologies, drugs and in vivo therapeutic solutions that are being produced by pioneers in the genome editing field. The congress will feature over 30 presentations in a comprehensive conference programme designed to provide an increased knowledge of current trends influencing gene editing research. Key speakers include Directors from Novartis, Pfizer, Harvard, MIT and more.
The congress covers the latest in Multi-Omic Single Cell Analysis - discuss and debate the critical challenges and opportunities in Genomic, Transcriptomics and Proteomics. Updates and highlights in Spatial Transcriptomics, Genomics and Digital Spatial Profiling as well as implications on sample and data analysis. Latest advancements in single cell analysis in drug discovery and development including key therapeutic applications in oncology, neurology and immuno-oncology, and the latest diagnostics development. Overcoming Challenges in library preparation, bioinformatics and multi-omic data integration.
Featuring a world-class panel of speakers and 20+ presentations, the congress will cover the latest in the future of NGS and long lead sequencing, and benefit from critical discussions and thought-provoking presentations on Long read sequencing For Human Genomes And De Novo Studies, Data analysis in denovo assembly and structural variants, Bioinformatics and mapping tools. Plus, Deliver Genomic Based Medicine - Applications of long and short read sequencing in the Clinic.